BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11426493)

  • 1. Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immunosuppressive therapy.
    Shimamoto T; Hayashi S; Ando K; Yguchi M; Miyazawa K; Kimura Y; Mukai K; Serizawa H; Ohyashiki K
    Am J Hematol; 2001 Jan; 66(1):49-52. PubMed ID: 11426493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma].
    Kobayashi K; Yokote T; Akioka T; Hara S; Oka S; Hiraoka N; Hirata Y; Miyoshi T; Tsuji M; Hanafusa T
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1327-30. PubMed ID: 17687225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma.
    Pedersen LM; Klausen TW; Davidsen UH; Johnsen HE
    Ann Hematol; 2005 Aug; 84(8):510-6. PubMed ID: 15834569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous diffuse large B-cell lymphoma, leg type, with features simulating POEMS syndrome.
    Nakayama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Miyoshi T; Oka S; Hiraoka N; Iwaki K; Takayama A; Takubo T; Tsuji M; Hanafusa T
    Eur J Haematol; 2010 Jan; 84(1):79-83. PubMed ID: 19558504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y
    Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma.
    Ho CL; Sheu LF; Li CY
    Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.
    Gergely L; Aleksza M; Váróczy L; Ponyi A; Sipka S; Illés A; Szegedi G
    Eur J Haematol; 2004 May; 72(5):336-41. PubMed ID: 15059068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-cytokine-producing CD30-positive diffuse large B-cell lymphoma.
    Nakayama-Ichiyama S; Yokote T; Oka S; Iwaki K; Kobayashi K; Akioka T; Hiraoka N; Takayama A; Takubo T; Tsuji M; Hanafusa T
    Leuk Res; 2010 Jul; 34(7):e164-6. PubMed ID: 20167370
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
    Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
    Kawakami K; Watanabe Y; Kadowaki S
    Rinsho Ketsueki; 2003 Mar; 44(3):168-73. PubMed ID: 12722343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple-cytokine-producing, mixed-cellularity, classical Hodgkin lymphoma with B symptoms and minimal-change nephrotic syndrome.
    Nakayama-Ichiyama S; Yokote T; Kobayashi K; Hirata Y; Akioka T; Hiraoka N; Takayama A; Iwaki K; Oka S; Takubo T; Tsuji M; Hanafusa T
    Leuk Res; 2010 Jul; 34(7):e157-9. PubMed ID: 20167371
    [No Abstract]   [Full Text] [Related]  

  • 15. Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Nishizaki D; Takamatsu T; Iwasa Y
    Hepatogastroenterology; 2008; 55(84):891-4. PubMed ID: 18705290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
    Cortes J; Kantarjian H; Albitar M; Thomas D; Faderl S; Koller C; Garcia-Manero G; Giles F; Andreeff M; O'Brien S; Keating M; Estey E
    Cancer; 2003 Mar; 97(5):1234-41. PubMed ID: 12599230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
    Elmahy H; Hawley I; Beard J
    Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
    McDonnell CO; Harmey JH; Bouchier-Hayes DJ; Walsh TN
    Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary diffuse large B-cell lymphoma of the bone marrow complicated with autoimmune hemolytic anemia and erythroid hypoplasia].
    Sumi M; Ichikawa N; Shimizu I; Yotsumoto M; Ueno M; Kobayashi H
    Rinsho Ketsueki; 2007 Jul; 48(7):571-5. PubMed ID: 17695307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.